SUMMARY Rivanol, the cationic salt of an acridine base, has been used as a novel separation procedure in an immunoradiometric assay for human liver ferritin. The separation step is based on the differences in charge and molecular weight between the labelled antibody-ferritin complex and free labelled immunoglobulins. The resultant assay is simple, reproducible and sufficiently sensitive to determine serum concentrations of ferritin.
All immunoradiometric assays (IRMA) are based on the use of specific antibodies labelled with a radionuclide and offer several advantages as compared with radioimmunoassays (RIA), which employ isotopically labelled antigen. ' 2 In a conventional IRMA, of the type first described by Miles and Hales, 34 sample (or standard) is incubated with an excess of the labelled antibodies and, once equilibrium has been reached, it is necessary to separate the remaining free labelled antibodies from those bound to the antigen. To date this has always been achieved by the addition of an immunoadsorbent comprising antigen covalently coupled to a solid phase.
Such a separation step is wasteful of purified antigen and prohibits the use of conventional IRMA for analytes that are either expensive or in short supply. This disadvantage is avoided in IRMA of the "twosite sandwich" type in which unlabelled antibodies coupled or adsorbed to a solid phase are used to bind all the antigen present in the sample (or standard) and the labelled specific antibodies to determine how much has been bound.5 However, this approach is limited to analytes having more than one antigenic determinant and is wasteful of antisera. As an alternative, it seemed likely that differences in charge and/or molecular weight between the antigen-labelled antibody complex and free labelled antibodies in some conventional IRMA might enable use of a simpler separation technique.
Horejsi and Smetana6 have shown that it is possible to precipitate all the main plasma proteins, other than the gamma globulins, by addition of a carefully chosen amount of rivanol at neutral or Accepted for publication 16 November 1982 440 slightly alkaline pH. The present paper describes a simple conventional IRMA for the iron storage protein, ferritin, in which rivanol is used to precipitate the ferritin-antibody complex while leaving the free labelled antibodies in the supernatant.
Material and methods
Rivanol, the cationic salt of the acridine base, 2-ethoxy 6,9-diaminoacridine lactate monohydrate, was supplied as a yellow powder of more than 97% purity by Koch-Light (Colnbrook, Berkshire); Sepharose 6B was obtained from Pharmacia (Hounslow, Middlesex); bovine serum albumin (BSA) and glutaraldehyde from Sigma (Poole, Dorset); potassium thiocyanate and potassium ferrocyanide from BDH (Poole, Dorset); human serum albumin (HSA) from Kabi (Stockholm, Sweden); Coomassie brilliant blue (R250) from Biorad (Richmond, USA); iodogen from Pierce Chemical (Rockford, USA); and carrier free Na'25I from Amersham International (Amersham, Buckinghamshire).
PREPARATION OF HUMAN LIVER FERRITIN
Ferritin was extracted and purified from human liver by a slight modification of the method of Aherne and Worwood.7 Thus the product from this method was chromatographed on a Sepharose 6B column (1-6 x 100 cm) equilibrated and eluted with 0*008 M Na2HPO4/0002 M NaH2PO4 adjusted to pH 7'5 with 1 M NaOH. The protein content of the final product was determined by the method of Lowry and his colleagues8 using HSA as a standard. Its purity was determined by 4% (wt/vol) polyacrylamide gel electrophoresis using glycine Tris buffer, pH 8-5 as described in a commercial instruction group.bmj.com on January 11, 2018 -Published by http://jcp.bmj.com/ Downloaded from manual (Shandon Southern Instruments, Runcorn, Cheshire). The gels were run in duplicate and one was stained for ferric iron using potassium ferrocyanide9 and the other for protein, with Coomassie brilliant blue. There was one main band representing the ferritin monomer and a smaller band due to ferritin polymer. The highly purified human liver ferritin was used as the immunogen, to prepare standards and as the immunoadsorbant.
PREPARATION OF SHEEP ANTIFERRITIN IMMUNOGLOBULINS
Three Border-Leicester ewes were each injected intramuscularly at several sites with human ferritin (200 gg in 2 ml of water) emulsified with complete Freund's adjuvant (6 ml). The sheep were reimmunised at seven week intervals, each with 100 jig of ferritin in incomplete Freund's adjuvant, and bled 10-days after each reimmunisation. All produced high titre antisera and the third bleed from one sheep (S-457-3) was used for all subsequent studies.
The specific antiferritin immunoglobulins from 1 ml of antiserum were extracted with 8 mg of immunosorbant, comprising human ferritin that had been polymerised using glutaraldehyde at a glutaraldehyde to ferritin ratio of 1:10 (wt/wt).'°A fter washing, the specific antibodies were eluted from the immunoadsorbant by use of 3 M potassium thiocyanate in 0*05 M NaH2PO4 adjusted to pH 6.0 with 1 M NaOH."
RADIOIODINATION OF SPECIFIC ANTIFERRITIN IMMUNOGLOBULINS
The purified sheep antiferritin immunoglobulins were radioiodinated by the iodogen technique. '2 Briefly, 50 ,ul of iodogen solution (40 ,ug/ml in dichloromethane) were allowed to evaporate to dryness in the bottom of a polypropylene tube. Iodine-125 (1251) (ImCi, 0*5 nmol) was added followed by 38 ,ug (0.25 nmol) of purified antibody in 38 ,u of 0-1 M sodium phosphate buffer, pH 7*5. The reaction was terminated after 10 min by transferring the reaction mixture to 500,ul of 0-05 M sodium phoshate buffer, pH 7-5. After a further 10 min the iodination mixture was chromatographed on a Sephadex G200 column (0-9 x 60 cm) previously equilibrated with 0-04 M Na2HP04/0-01 M NaH2PO4 adjusted to pH 7-5 with 1 M NaOH, containing BSA (0-5% wt/vol) and sodium azide (0-2% wt/vol). The fractions from the peak comprising the 1251 labelled immunoglobulins were pooled and stored at -20 'C.
In a series of 10 radioiodinations, the mean (+SD) incorporation of 125I was 70-5 + 3-5% and the specific activity of the labelled product ranged from 17-6 to 19-5 ,uCi/,ug of IgG. The labelled product was stable for at least 10 wk at -20 'C and more than 65% bound to an excess of the immunoadsorbant.
SAMPLES AND STANDARDS
Serum samples from 91 patients were provided by Dr S Woodhead of the Welsh School of Medicine. These had all been assayed by a "two-site" immunoradiometric automated technique (S Woodhead, personal communication, 1982) .
Ferritin-free serum was obtained by incubating pooled normal human serum with sheep antiferritin serum covalently coupled to magnetisable particles as described previously.'3 After ovemight rotatory mixing, the particles were sedimented on a magnetic block and the serum supernatant demonstrated to contain no measurable ferritin. Sodium azide was added (0.2%) and 10 ml aliquots stored at -20°C.
Highly purified ferritin standards were prepared in standard buffer (0-05 M sodium phosphate buffer, pH 7 5, containing BSA (4%)) at a concentration of 1000 ,g/l and stored in 0.5 ml aliquots at -200 C.
ASSAY PROTOCOL Patients' samples (previously diluted 1/10 in standard buffer) or standards, ranging from 0-5 to 1000 ,g/l (100 ,lA) were incubated with 150 ,l of 1251_ labelled specific antiferritin antibodies (sufficient to give 100 000 cpm) in assay buffer (0X5 M sodium phosphate buffer, pH 7*5 containing 0.1% BSA) at room temperature.
After equilibrium had been reached the rivanol solution in 0*05 M sodium phosphate buffer pH 7-5 was added and, after a short further incubation period, the tubes were centrifuged, the supernates decanted and the precipitates (containing the ferritin-anti-ferritin-complex) counted for 60 s.
Results

STUDIES OF THE RIVANOL SEPARATION STEP
Horejsi and Smetana6 have demonstrated the critical importance of pH and of the volume and concentration of rivanol in the differential precipitation of plasma proteins. Therefore, studies were undertaken of the rivanol separation step by employing tubes containing the top standard (1000 Ag/l) and excess labelled specific antibodies and, in others, labelled antibodies in the absence of human liver ferritin. A concentration of 0-05% rivanol was chosen on the basis of initial experiments and from 50 to 1250 ul was added to each tube. Less than 5% of the labelled antibodies alone were precipitated but addition of 1 ml, or more, resulted in complete precipitation of the ferritin-antibody complex (Fig. 1) . was added. Neither the free labelled antibodies nor the antigen-antibody complex were precipitated over the pH range 3-5. However, separation was achieved between pH 7-5 and 10 ( Fig. 2) and phosphate buffer, pH 7-5 was chosen in order to minimise non-specific precipitation.
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In further experiments it was shown necessary to leave the tubes 10 min after the addition of the rivanol before centrifugation and that separation was not improved by longer periods up to 24 h. Centrifugation for 10 min at 1000 rpm was sufficient to ensure maximum precipitation whether at 40, 250, or 37°C.
OPTIMISATION AND VALIDATION OF ASSAY Standard curves were set up and incubated for from 10 min to 8 h. Equilibrium was attained in 120 min when the standard curve covered the clinically important range for diagnosing iron deficiency'4 (Fig. 3) . Use of four different amounts of the 125I. specific antibodies was studied and that sufficient to give 100 000 cpm found most suitable. Use of 100 ,u1 of undiluted ferritin-free serum affected the assay non-specifically but this was avoided by diluting all samples 1/10, or more, in phosphate buffer, pH 7.5, containing BSA (4%).
The sensitivity of the IRMA, as determined by the method of Rodbard,'5 was 10 ,ug/l of serum and, by appropriate sample dilution, it was possible to assay all samples. Recovery, as determined by adding from 1 lug/l to 125 ,ug/l of human liver ferritin to three serum pools was in the range of 92-1 to 106-1%. Within-assay variation as assessed by assaying four individual samples 10 times in an assay ranged from 2-7 to 8-0%; the between-assay coefficient of variation for the same samples assayed in duplicate in 10 different assays ranged from 3-3 to 10.0% (Table 1) .
Of the Concentration of ferritin (ug/l) (Cardiff assay) Fig. 4 Correlation between the results ebtained on 66 samples by the Cardiffassay and by our assay using rivanol separation.
in agreement with this. A comparison of the results obtained with the present assay for the remaining 66 samples is shown in Fig. 4 .
Discussion
It has been assumed that the only means of separating excess free labelled specific antibodies from the antigen-labelled antibody complex in a conventional IRMA is by means of an immunosorbant which limits this analytical approach to analytes that are inexpensive and widely available. Ferritin is a much larger molecule than IgG and it seemed likely that simpler means could be devised for the separation step. Selective precipitation of the antigen-antibody complex seemed one obvious approach and, in the present study, rivanol has proved suitable for this purpose. The resultant assay is simple, rapid and sufficiently sensitive and precise for clinical purposes.
There is no doubt that other means of selectively precipitating the bound fraction could be devised 
